← Back to Screener
Tevogen Bio Holdings Inc. Warrant (TVGNW)
Price$0.04
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-14.80%
Price vs S&P 500 (4W)17.99%
VGM Score59.64
All Metrics
Price vs S&P 500 (YTD)-6.78%
10-Day Avg Trading Volume0.16M
3-Month Avg Trading Volume0.12M
52-Week High$0.08
26-Week Price Return-6.87%
13-Week Price Return-3.23%
3-Month Return Std Dev81.00%
Year-to-Date Return-0.47%
5-Day Price Return5.79%
Month-to-Date Return5.26%
Price vs S&P 500 (13W)-11.48%
Beta0.03x
52-Week Low$0.03
mGradeC
vgmGradeC
Show chart for
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
TVGNWTevogen Bio Holdings Inc. Warrant | — | — | C | $0.04 |
| AMGNAmgen Inc | C | C | C | $349.58 |
| GILDGilead Sciences Inc | C | B | C | $129.16 |
| ARGXargenx SE American Depositary Shares | D | A | B | $891.32 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $149.23 |
| BIIBBiogen Inc. Common Stock | B | D | B | $195.34 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.08 |
| MRNAModerna, Inc. Common Stock | C | B | B | $47.44 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $163.88 |
| EXELExelixis Inc | C | B | B | $52.70 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | A | $301.00 |
About
Tevogen Bio Holdings Inc is a clinical-stage immunotherapy company developing off-the-shelf T cell therapies designed to harness the immune system's ability to fight disease. The company's platform leverages CD8+ cytotoxic T lymphocytes to create precision cell therapies with the potential to treat infectious diseases, cancers, and neurological disorders. By focusing on ready-to-use cell therapies rather than patient-specific treatments, Tevogen aims to improve accessibility and scalability in the immunotherapy market.